Literature DB >> 19592606

The National Children's Study: a golden opportunity to advance the health of pregnant women.

Anne Drapkin Lyerly1, Margaret Olivia Little, Ruth R Faden.   

Abstract

With a $3 billion investment by the federal government, the National Children's Study (NCS) recently began recruitment. The NCS is a golden-and potentially missed-opportunity to study one of the most underrepresented populations in clinical research: pregnant women. As the nation's largest-ever study of children's health, the NCS will examine the effects of the environment on children from before birth to 21 years of age, with participants sampled primarily through women during pregnancy. Thus the NCS presents a rare opportunity to study the health of women during and after pregnancy, in addition to the health of their children. On both moral and policy grounds, we make the case for inclusion of women's health outcomes in the NCS.

Entities:  

Mesh:

Year:  2009        PMID: 19592606      PMCID: PMC2741507          DOI: 10.2105/AJPH.2009.165498

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  19 in total

1.  Asthma prevalence among pregnant and childbearing-aged women in the United States: estimates from national health surveys.

Authors:  Helen L Kwon; Kathleen Belanger; Michael B Bracken
Journal:  Ann Epidemiol       Date:  2003-05       Impact factor: 3.797

Review 2.  The cardiovascular complications of pregnancy.

Authors:  Cary Ward; Cheryl D Bushnell; Andra H James
Journal:  Prog Cardiovasc Dis       Date:  2007 Sep-Oct       Impact factor: 8.194

3.  Drug safety in pregnant women and their babies: ignorance not bliss.

Authors:  C D Chambers; J E Polifka; J M Friedman
Journal:  Clin Pharmacol Ther       Date:  2007-12-12       Impact factor: 6.875

4.  Obstetric clinical pharmacology: coming of age.

Authors:  A Zajicek; G P Giacoia
Journal:  Clin Pharmacol Ther       Date:  2007-04       Impact factor: 6.875

Review 5.  Asthma in pregnancy.

Authors:  K S Tan; N C Thomson
Journal:  Am J Med       Date:  2000-12-15       Impact factor: 4.965

6.  Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies.

Authors:  M A Andrew; T R Easterling; D B Carr; D Shen; M L Buchanan; T Rutherford; R Bennett; P Vicini; M F Hebert
Journal:  Clin Pharmacol Ther       Date:  2007-02-28       Impact factor: 6.875

7.  The second wave: Toward responsible inclusion of pregnant women in research.

Authors:  Anne Drapkin Lyerly; Margaret Olivia Little; Ruth Faden
Journal:  Int J Fem Approaches Bioeth       Date:  2008

Review 8.  Use of chemotherapy during human pregnancy.

Authors:  Elyce Cardonick; Audrey Iacobucci
Journal:  Lancet Oncol       Date:  2004-05       Impact factor: 41.316

9.  Depressive symptoms and indicators of maternal health status during pregnancy.

Authors:  Suezanne T Orr; Dan G Blazer; Sherman A James; Jerome P Reiter
Journal:  J Womens Health (Larchmt)       Date:  2007-05       Impact factor: 2.681

10.  Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice.

Authors:  M F Hebert; X Ma; S B Naraharisetti; K M Krudys; J G Umans; G D V Hankins; S N Caritis; M Miodovnik; D R Mattison; J D Unadkat; E J Kelly; D Blough; C Cobelli; M S Ahmed; W R Snodgrass; D B Carr; T R Easterling; P Vicini
Journal:  Clin Pharmacol Ther       Date:  2009-03-18       Impact factor: 6.903

View more
  7 in total

1.  Recruitment of women in the National Children's Study Initial Vanguard Study.

Authors:  Dean Baker; Christina Park; Carol Sweeney; Lacey McCormack; Maureen Durkin; Ruth Brenner; Dana Dabelea; Barbara Entwisle
Journal:  Am J Epidemiol       Date:  2014-05-02       Impact factor: 4.897

2.  Developmental and environmental origins of breast cancer: DDT as a case study.

Authors:  Barbara A Cohn
Journal:  Reprod Toxicol       Date:  2010-10-19       Impact factor: 3.143

3.  Enrolling pregnant women: issues in clinical research.

Authors:  Mary C Blehar; Catherine Spong; Christine Grady; Sara F Goldkind; Leyla Sahin; Janine A Clayton
Journal:  Womens Health Issues       Date:  2013-01

4.  The perils of protection: vulnerability and women in clinical research.

Authors:  Toby Schonfeld
Journal:  Theor Med Bioeth       Date:  2013-06

5.  'Experimental pregnancy' revisited.

Authors:  Anne Drapkin Lyerly
Journal:  Theor Med Bioeth       Date:  2022-07-20

6.  Population-level benefits from providing effective HIV prevention means to pregnant women in high prevalence settings.

Authors:  Dobromir Dimitrov; Marie-Claude Boily; Jeannie Marrazzo; Richard Beigi; Elizabeth R Brown
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

Review 7.  The moral imperative to approve pregnant women's participation in randomized clinical trials for pregnancy and newborn complications.

Authors:  Dan Kabonge Kaye
Journal:  Philos Ethics Humanit Med       Date:  2019-09-06       Impact factor: 2.464

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.